Cargando…

Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping

Use of whole-genome sequencing (WGS) for routine mycobacterial species identification and drug susceptibility testing (DST) is becoming a reality. We compared the performances of WGS and standard laboratory workflows prospectively, by parallel processing at a major mycobacterial reference service ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, T. Phuong, Bawa, Zharain, Foster, Dona, Walker, Tim, del Ojo Elias, Carlos, Rathod, Priti, Iqbal, Zamin, Bradley, Phelim, Mowbray, Janet, Walker, A. Sarah, Crook, Derrick W., Wyllie, David H., Peto, Timothy E. A., Smith, E. Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786738/
https://www.ncbi.nlm.nih.gov/pubmed/29167290
http://dx.doi.org/10.1128/JCM.01480-17
_version_ 1783295823289778176
author Quan, T. Phuong
Bawa, Zharain
Foster, Dona
Walker, Tim
del Ojo Elias, Carlos
Rathod, Priti
Iqbal, Zamin
Bradley, Phelim
Mowbray, Janet
Walker, A. Sarah
Crook, Derrick W.
Wyllie, David H.
Peto, Timothy E. A.
Smith, E. Grace
author_facet Quan, T. Phuong
Bawa, Zharain
Foster, Dona
Walker, Tim
del Ojo Elias, Carlos
Rathod, Priti
Iqbal, Zamin
Bradley, Phelim
Mowbray, Janet
Walker, A. Sarah
Crook, Derrick W.
Wyllie, David H.
Peto, Timothy E. A.
Smith, E. Grace
author_sort Quan, T. Phuong
collection PubMed
description Use of whole-genome sequencing (WGS) for routine mycobacterial species identification and drug susceptibility testing (DST) is becoming a reality. We compared the performances of WGS and standard laboratory workflows prospectively, by parallel processing at a major mycobacterial reference service over the course of 1 year, for species identification, first-line Mycobacterium tuberculosis resistance prediction, and turnaround time. Among 2,039 isolates with line probe assay results for species identification, 74 (3.6%) failed sequencing or WGS species identification. Excluding these isolates, clinically important species were identified for 1,902 isolates, of which 1,825 (96.0%) were identified as the same species by WGS and the line probe assay. A total of 2,157 line probe test results for detection of resistance to the first-line drugs isoniazid and rifampin were available for 728 M. tuberculosis complex isolates. Excluding 216 (10.0%) cases where there were insufficient sequencing data for WGS to make a prediction, overall concordance was 99.3% (95% confidence interval [CI], 98.9 to 99.6%), sensitivity was 97.6% (91.7 to 99.7%), and specificity was 99.5% (99.0 to 99.7%). A total of 2,982 phenotypic DST results were available for 777 M. tuberculosis complex isolates. Of these, 356 (11.9%) had no WGS comparator due to insufficient sequencing data, and in 154 (5.2%) cases the WGS prediction was indeterminate due to discovery of novel, previously uncharacterized mutations. Excluding these data, overall concordance was 99.2% (98.7 to 99.5%), sensitivity was 94.2% (88.4 to 97.6%), and specificity was 99.4% (99.0 to 99.7%). Median processing times for the routine laboratory tests versus WGS were similar overall, i.e., 20 days (interquartile range [IQR], 15 to 31 days) and 21 days (15 to 29 days), respectively (P = 0.41). In conclusion, WGS predicts species and drug susceptibility with great accuracy, but work is needed to increase the proportion of predictions made.
format Online
Article
Text
id pubmed-5786738
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-57867382018-02-07 Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping Quan, T. Phuong Bawa, Zharain Foster, Dona Walker, Tim del Ojo Elias, Carlos Rathod, Priti Iqbal, Zamin Bradley, Phelim Mowbray, Janet Walker, A. Sarah Crook, Derrick W. Wyllie, David H. Peto, Timothy E. A. Smith, E. Grace J Clin Microbiol Mycobacteriology and Aerobic Actinomycetes Use of whole-genome sequencing (WGS) for routine mycobacterial species identification and drug susceptibility testing (DST) is becoming a reality. We compared the performances of WGS and standard laboratory workflows prospectively, by parallel processing at a major mycobacterial reference service over the course of 1 year, for species identification, first-line Mycobacterium tuberculosis resistance prediction, and turnaround time. Among 2,039 isolates with line probe assay results for species identification, 74 (3.6%) failed sequencing or WGS species identification. Excluding these isolates, clinically important species were identified for 1,902 isolates, of which 1,825 (96.0%) were identified as the same species by WGS and the line probe assay. A total of 2,157 line probe test results for detection of resistance to the first-line drugs isoniazid and rifampin were available for 728 M. tuberculosis complex isolates. Excluding 216 (10.0%) cases where there were insufficient sequencing data for WGS to make a prediction, overall concordance was 99.3% (95% confidence interval [CI], 98.9 to 99.6%), sensitivity was 97.6% (91.7 to 99.7%), and specificity was 99.5% (99.0 to 99.7%). A total of 2,982 phenotypic DST results were available for 777 M. tuberculosis complex isolates. Of these, 356 (11.9%) had no WGS comparator due to insufficient sequencing data, and in 154 (5.2%) cases the WGS prediction was indeterminate due to discovery of novel, previously uncharacterized mutations. Excluding these data, overall concordance was 99.2% (98.7 to 99.5%), sensitivity was 94.2% (88.4 to 97.6%), and specificity was 99.4% (99.0 to 99.7%). Median processing times for the routine laboratory tests versus WGS were similar overall, i.e., 20 days (interquartile range [IQR], 15 to 31 days) and 21 days (15 to 29 days), respectively (P = 0.41). In conclusion, WGS predicts species and drug susceptibility with great accuracy, but work is needed to increase the proportion of predictions made. American Society for Microbiology 2018-01-24 /pmc/articles/PMC5786738/ /pubmed/29167290 http://dx.doi.org/10.1128/JCM.01480-17 Text en Copyright © 2018 Quan et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Mycobacteriology and Aerobic Actinomycetes
Quan, T. Phuong
Bawa, Zharain
Foster, Dona
Walker, Tim
del Ojo Elias, Carlos
Rathod, Priti
Iqbal, Zamin
Bradley, Phelim
Mowbray, Janet
Walker, A. Sarah
Crook, Derrick W.
Wyllie, David H.
Peto, Timothy E. A.
Smith, E. Grace
Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping
title Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping
title_full Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping
title_fullStr Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping
title_full_unstemmed Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping
title_short Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping
title_sort evaluation of whole-genome sequencing for mycobacterial species identification and drug susceptibility testing in a clinical setting: a large-scale prospective assessment of performance against line probe assays and phenotyping
topic Mycobacteriology and Aerobic Actinomycetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786738/
https://www.ncbi.nlm.nih.gov/pubmed/29167290
http://dx.doi.org/10.1128/JCM.01480-17
work_keys_str_mv AT quantphuong evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT bawazharain evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT fosterdona evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT walkertim evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT delojoeliascarlos evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT rathodpriti evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT iqbalzamin evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT bradleyphelim evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT mowbrayjanet evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT walkerasarah evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT crookderrickw evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT wylliedavidh evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT petotimothyea evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping
AT smithegrace evaluationofwholegenomesequencingformycobacterialspeciesidentificationanddrugsusceptibilitytestinginaclinicalsettingalargescaleprospectiveassessmentofperformanceagainstlineprobeassaysandphenotyping